title: [Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives].
abstract: Sulfasalazine is one of the most used drugs in the clinical management of inflammatory bowel disease. Nevertheless up to 30% of the patients experiment side effects related to the drug and end up having the drug diminished or withdrawn. The new salicylic-derivate compounds emerge as a reliable alternative for these patients. The authors review the new preparations and discuss their characteristics, indications and side effects.
authors.forename: A O
authors.initials: AO
authors.lastname: Damião
authors.forename: A M
authors.initials: AM
authors.lastname: Sipahi
mesh_terms: D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019804:Mesalamine; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000636:Aminosalicylic Acids; D012460:Sulfasalazine; D019804:Mesalamine
vernacular_title: Derivados salicílicos no tratamento clínico da doença inflamatória intestinal: novas perspectivas.